Gracell Biotechnologies Inc. (GRCL) — Defensive Interval Ratio
Gracell Biotechnologies Inc. (GRCL) has a Defensive Interval Ratio of 48 days as of September 2023. Defensive assets of $30.46 Million (cash $-, short-term investments $30.46 Million, receivables $-) cover 48 days of daily cash needs of $628.70K/day. Check how tangible is Gracell Biotechnologies Inc.'s equity to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Gracell Biotechnologies Inc. Defensive Interval Ratio (2018–2022)
This chart shows how Gracell Biotechnologies Inc.'s Defensive Interval Ratio has evolved across 5 annual periods from 2018 to 2022. As of September 2023, the ratio stands at 48 days, meaning defensive assets of $30.46 Million can fund 48 days of operations without new revenue. Also explore Gracell Biotechnologies Inc. (GRCL) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Gracell Biotechnologies Inc. (2018–2022)
The table below presents the year-by-year Defensive Interval Ratio for Gracell Biotechnologies Inc. from 2018 to 2022, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see GRCL stock market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2022 | 49 days | $29.89 Million | $604.50K/day | $- | $3.56 Million | ▼ -55 days |
| 2021 | 104 days | $44.30 Million | $424.99K/day | $- | $3.62 Million | ▼ -90 days |
| 2020 | 194 days | $49.70 Million | $255.78K/day | $- | $18.74 Million | ▼ -167 days |
| 2019 | 361 days | $17.97 Million | $49.77K/day | $- | $4.20 Million | ▼ -4947 days |
| 2018 | 5308 days | $108.20 Million | $20.38K/day | $- | $102.00 Million | — |